These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

307 related articles for article (PubMed ID: 28418340)

  • 1. Risk Adapted Management of Febrile Neutrepenia and Early Cessation of Empirical Antibiotherapy in Hematopoietic Stem Cell Transplantation Setting.
    Kaya AH; Tekgündüz E; Duygu F; Koca D; Bekdemir F; Batgi H; Ulu Uncu B; Yiğenoğlu TN; Dal MS; Çakar Kızıl M; Altuntaş F
    Balkan Med J; 2017 Apr; 34(2):132-139. PubMed ID: 28418340
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Piperacillin-tazobactam vs. imipenem-cilastatin as empirical therapy in hematopoietic stem cell transplantation recipients with febrile neutropenia.
    Jing Y; Li J; Yuan L; Zhao X; Wang Q; Yu L; Zhou D; Huang W
    Clin Transplant; 2016 Mar; 30(3):263-9. PubMed ID: 26701371
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Changes in the microbiological epidemiology of febrile neutropenia in autologous stem cell transplant recipients.
    Rönkkö R; Juutilainen A; Koivula I; Vänskä M; Nousiainen T; Jantunen E; Hämäläinen S
    Infect Dis (Lond); 2018 Jun; 50(6):436-442. PubMed ID: 29303041
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antimicrobial de-escalation in adult hematopoietic cell transplantation recipients with febrile neutropenia of unknown origin.
    Petteys MM; Kachur E; Pillinger KE; He J; Copelan EA; Shahid Z
    J Oncol Pharm Pract; 2020 Apr; 26(3):632-640. PubMed ID: 31423947
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Early discontinuation of empirical antibacterial therapy in febrile neutropenia: the ANTIBIOSTOP study.
    Le Clech L; Talarmin JP; Couturier MA; Ianotto JC; Nicol C; Le Calloch R; Dos Santos S; Hutin P; Tandé D; Cogulet V; Berthou C; Guillerm G
    Infect Dis (Lond); 2018 Jul; 50(7):539-549. PubMed ID: 29451055
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Measurement of C-reactive protein in adults with febrile neutropenia after hematopoietic cell transplantation.
    Ortega M; Rovira M; Almela M; de la Bellacasa JP; Carreras E; Mensa J
    Bone Marrow Transplant; 2004 Apr; 33(7):741-4. PubMed ID: 14730343
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluation of febrile neutropenia in patients undergoing hematopoietic stem cell transplantation.
    Amini S; Hadjibabaie M; Jahangard-Rafsanjani Z; Ashuri A; Torkamandi H; Ghavamzadeh A
    Acta Med Iran; 2014; 52(1):38-42. PubMed ID: 24658984
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Is current initial empirical antibiotherapy appropriate to treat bloodstream infections in short-duration chemo-induced febrile neutropenia?
    Joncour A; Puyade M; Michaud A; Tourani JM; Cazenave-Roblot F; Rammaert B
    Support Care Cancer; 2020 Jul; 28(7):3103-3111. PubMed ID: 31667604
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Febrile neutropenia in paediatric peripheral blood stem cell transplantation, in -vitro sensitivity data and clinical response to empirical antibiotic therapy.
    Ansari SH; Nasim S; Ahmed A; Irfan M; Ishaque A; Farzana T; Panjwani VK; Taj M; Shamsi TS
    J Coll Physicians Surg Pak; 2006 Nov; 16(11):704-8. PubMed ID: 17052420
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluating Antibiotic De-escalation for Autologous Stem Cell Transplant Patients With Febrile Neutropenia in a Real-World Clinical Setting.
    Winget MD; Gatwood K; Jayani R; Biltibo E; Jallouk A; Jerkins J; Dholaria B; Kim TK; Savani B; Kassim A; McNeer E; Choi L; Orton L
    Transplant Cell Ther; 2024 Oct; 30(10):1031.e1-1031.e9. PubMed ID: 39074685
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Febrile neutropenia management and outcomes in hematopoietic cell transplantation for chronic granulomatous disease.
    Parta M; Cuellar-Rodriguez J; Gea-Banacloche J; Qin J; Kelly C; Zerbe CS; Holland SM; Malech HL; Kang EM
    Transpl Infect Dis; 2022 Apr; 24(2):e13815. PubMed ID: 35191140
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Guideline for the Management of Fever and Neutropenia in Children With Cancer and Hematopoietic Stem-Cell Transplantation Recipients: 2017 Update.
    Lehrnbecher T; Robinson P; Fisher B; Alexander S; Ammann RA; Beauchemin M; Carlesse F; Groll AH; Haeusler GM; Santolaya M; Steinbach WJ; Castagnola E; Davis BL; Dupuis LL; Gaur AH; Tissing WJE; Zaoutis T; Phillips R; Sung L
    J Clin Oncol; 2017 Jun; 35(18):2082-2094. PubMed ID: 28459614
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of meropenem administration in extended infusion on the clinical outcome of febrile neutropenia: a retrospective observational study.
    Fehér C; Rovira M; Soriano A; Esteve J; Martínez JA; Marco F; Carreras E; Martínez C; Fernández-Avilés F; Suárez-Lledó M; Mensa J
    J Antimicrob Chemother; 2014 Sep; 69(9):2556-62. PubMed ID: 24855125
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Piperacillin/tazobactam vs. cefoperazone/sulbactam in adult low-risk febrile neutropenia cases.
    Sipahi OR; Arda B; Nazli-Zeka A; Pullukcu H; Tasbakan M; Yamazhan T; Ozkoren-Calik S; Sipahi H; Ulusoy S
    Int J Clin Pract; 2014 Feb; 68(2):230-5. PubMed ID: 24372736
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Strategies for Empiric Management of Pediatric Fever and Neutropenia in Patients With Cancer and Hematopoietic Stem-Cell Transplantation Recipients: A Systematic Review of Randomized Trials.
    Robinson PD; Lehrnbecher T; Phillips R; Dupuis LL; Sung L
    J Clin Oncol; 2016 Jun; 34(17):2054-60. PubMed ID: 27022114
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Febrile neutropenic infection occurred in cancer patients undergoing autologous peripheral blood stem cell transplantation.
    Zhang WX; Zhao QY; Huang HQ
    Transplant Proc; 2015 Mar; 47(2):523-7. PubMed ID: 25769601
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Febrile neutropenia in allogeneic and autologous peripheral blood stem cell transplantation and conventional chemotherapy for malignancies.
    Celebi H; Akan H; Akçağlayan E; Ustün C; Arat M
    Bone Marrow Transplant; 2000 Jul; 26(2):211-4. PubMed ID: 10918433
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Risk of febrile neutropenia among patients with multiple myeloma or lymphoma who undergo inpatient versus outpatient autologous stem cell transplantation: a systematic review and meta-analysis.
    Owattanapanich W; Suphadirekkul K; Kunacheewa C; Ungprasert P; Prayongratana K
    BMC Cancer; 2018 Nov; 18(1):1126. PubMed ID: 30445930
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Impact of time to antibiotic on hospital stay, intensive care unit admission, and mortality in febrile neutropenia.
    Daniels LM; Durani U; Barreto JN; O'Horo JC; Siddiqui MA; Park JG; Tosh PK
    Support Care Cancer; 2019 Nov; 27(11):4171-4177. PubMed ID: 30805726
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Infectious complications after autologous hematopoietic stem cell transplantation: comparison of patients with acute myeloid leukemia, malignant lymphoma, and multiple myeloma.
    Auner HW; Sill H; Mulabecirovic A; Linkesch W; Krause R
    Ann Hematol; 2002 Jul; 81(7):374-7. PubMed ID: 12185506
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.